Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omega Therapeutics (OMGA)
NASDAQ:OMGA
Omega Therapeutics (OMGA) Stock Price & Analysis
278 Followers
OMGA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.30 - $10.09
Previous Close$2.41
Volume448.45K
Average Volume (3M)488.57K
Market Cap
$138.71M
Enterprise Value$193.69M
Total Cash (Recent Filing)$73.43M
Total Debt (Recent Filing)$128.40M
Price to Earnings (P/E)-1.3
Beta2.00
Next Earnings
May 02, 2024EPS Estimate
-$0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.81
Shares Outstanding55,154,985
10 Day Avg. Volume361,980
30 Day Avg. Volume488,573
Standard Deviation0.33
R-Squared0.09
Alpha-0.00515
Financial Highlights & Ratios
Price to Book (P/B)2.54
Price to Sales (P/S)44.83
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue62.60
Enterprise Value/Gross Profit62.60
Enterprise Value/Ebitda-4.46
Forecast
1Y Price Target
$9.00Price Target Upside273.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Omega Therapeutics News
Ownership Overview
65.68% Insiders
9.55% Mutual Funds
3.87% Other Institutional Investors
20.90% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMGA FAQ
What was Omega Therapeutics’s price range in the past 12 months?
Omega Therapeutics lowest stock price was $1.30 and its highest was $10.09 in the past 12 months.
What is Omega Therapeutics’s market cap?
Currently, no data Available
When is Omega Therapeutics’s upcoming earnings report date?
Omega Therapeutics’s upcoming earnings report date is May 02, 2024 which is in 14 days.
How were Omega Therapeutics’s earnings last quarter?
Omega Therapeutics released its earnings results on Mar 28, 2024. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.448 by $0.078.
Is Omega Therapeutics overvalued?
According to Wall Street analysts Omega Therapeutics’s price is currently Undervalued.
Does Omega Therapeutics pay dividends?
Omega Therapeutics does not currently pay dividends.
What is Omega Therapeutics’s EPS estimate?
Omega Therapeutics’s EPS estimate is -$0.33.
How many shares outstanding does Omega Therapeutics have?
Omega Therapeutics has 55,154,984 shares outstanding.
What happened to Omega Therapeutics’s price movement after its last earnings report?
Omega Therapeutics reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.448. Following the earnings report the stock price went up 2.817%.
Which hedge fund is a major shareholder of Omega Therapeutics?
Among the largest hedge funds holding Omega Therapeutics’s share is Flagship Pioneering Inc.. It holds Omega Therapeutics’s shares valued at 88M.
---
Omega Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (273.44% Upside)
$9.00 (273.44% Upside)
Blogger Sentiment
Bullish
OMGA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 50.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.6%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-66.73%
12-Months-Change
Fundamentals
Return on Equity
-118.82%
Trailing 12-Months
Asset Growth
39.98%
Trailing 12-Months
Company Description
Omega Therapeutics
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease.
---
OMGA Stock 12 Months Forecast
Average Price Target
$9.00
▲(273.44% Upside)
Technical Analysis
Applied Therapeutics
―
G1 Therapeutics
―
Ultragenyx Pharmaceutical
―
Sarepta Therapeutics
―
Best Analysts Covering OMGA
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
+19.82%
reiterated a buy rating 15 days ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +19.82% per trade.
---